Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,deferredLongTermLiab,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,otherCashflowsFromFinancingActivities,netBorrowings,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,preMarketChange,preMarketChangePercent,preMarketTime,preMarketPrice,regularMarketChangePercent,regularMarketDayRange,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jun 14, 2021) 4","Short Ratio (Jun 14, 2021) 4","Short % of Float (Jun 14, 2021) 4","Short % of Shares Outstanding (Jun 14, 2021) 4","Shares Short (prior month May 13, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,IDXX,406141000,85280704,37579000,,240090000,739000,204257000,185581000,470782000,247622000,247622000,,-7584000,,,,35801000,777707000,530085000,306925000,-7532000,,204289000,204257000,53969000,1321086000,1623950000,702696000,119313000,101122000,2327385000,10668000,63213000,2379852000,146326000,242586000,-3008910000,295504000,351163000,620662000,28340000,124971000,-54987000,637528000,1097798000,423101000,778747000,225559000,87175000,173000.0,-24587000.0,-129651000.0,-57081000.0,17594000.0,-32765000.0,-147245000.0,-2949000.0,124422000.0,25057000.0,-7919000.0,-54735000.0,14670000.0,-20163000.0,,,477136000,en-US,US,EQUITY,True,Delayed Quote,NMS,USD,676.9,1630526403,3.1400146,671.64,678.42,659.27,394867,673.76,0.0,0.0,8,8,finmb_29729,NasdaqGS,"IDEXX Laboratories, Inc.",USD,353360,400700,329.36002,0.9476895,347.54 - 706.95,-30.049988,-0.042506523,347.54,706.95,1620109808,1635337800,1635769800,87.10591,PRE,us_market,"IDEXX Laboratories, Inc.",0,False,False,2,0.0,0.0,1630570607,676.9,0.4660435,659.27 - 678.42,7.771,9.1,8.37,80.87217,8.232,679.24774,-2.3477173,-0.003456349,579.6309,97.269104,0.16781214,57726509056,74.38461,82.22789,15,America/New_York,EDT,-14400000,0.89,,,706.95,347.54,679.25,579.63,353.36k,400.7k,85.28M,,84.43M,0.95%,87.56%,852.23k,2.66,1.13%,1.00%,701.34k,,,,,,0.00%,,,2:1,"Jun 15, 2015","Dec 30, 2020","Mar 30, 2021",23.59%,27.92%,23.67%,166.25%,2.86B,33.48,24.20%,1.57B,895.67M,674.21M,7.77,82.70%,351.16M,4.12,999.84M,142.14,1.77,8.23,744.61M,557.21M,Value,04092,Healthcare,9300,5,4,"IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.",Westbrook,207 556 0300,ME,8,1609372800,1622505600,1,United States,http://www.idexx.com,86400,5,One IDEXX Drive,207 556 4346,Diagnostics & Research
t-1,IDXX,336198000,85280704,38777000,,177436000,707000,174790000,185630000,409502000,185095000,185095000,,-7828000,,,,2478000,720938000,535843000,311436000,-7659000,,174958000,174790000,52543000,1294849000,1661766000,632088000,116088000,85243000,2294561000,10646000,59639000,2175595000,143448000,243347000,-2849002000,289595000,383928000,582761000,31549000,49988000,-49112000,646338000,1062738000,374742000,858492000,209873000,74558000,-2471000.0,-15690000.0,398000.0,29659000.0,12098000.0,208341000.0,-11574000.0,4699000.0,218934000.0,24561000.0,6206000.0,11687000.0,-25498000.0,-14190000.0,-126000.0,,479977000,en-US,US,EQUITY,True,Delayed Quote,NMS,USD,676.9,1630526403,3.1400146,671.64,678.42,659.27,394867,673.76,0.0,0.0,8,8,finmb_29729,NasdaqGS,"IDEXX Laboratories, Inc.",USD,353360,400700,329.36002,0.9476895,347.54 - 706.95,-30.049988,-0.042506523,347.54,706.95,1620109808,1635337800,1635769800,87.10591,PRE,us_market,"IDEXX Laboratories, Inc.",0,False,False,2,0.0,0.0,1630570607,676.9,0.4660435,659.27 - 678.42,7.771,9.1,8.37,80.87217,8.232,679.24774,-2.3477173,-0.003456349,579.6309,97.269104,0.16781214,57726509056,74.38461,82.22789,15,America/New_York,EDT,-14400000,0.89,,,706.95,347.54,679.25,579.63,353.36k,400.7k,85.28M,,84.43M,0.95%,87.56%,852.23k,2.66,1.13%,1.00%,701.34k,,,,,,0.00%,,,2:1,"Jun 15, 2015","Dec 30, 2020","Mar 30, 2021",23.59%,27.92%,23.67%,166.25%,2.86B,33.48,24.20%,1.57B,895.67M,674.21M,7.77,82.70%,351.16M,4.12,999.84M,142.14,1.77,8.23,744.61M,557.21M,Value,04092,Healthcare,9300,5,4,"IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.",Westbrook,207 556 0300,ME,8,1609372800,1622505600,1,United States,http://www.idexx.com,86400,5,One IDEXX Drive,207 556 4346,Diagnostics & Research
t-2,IDXX,149009000,85280704,37517000,,163954000,539000,146219000,213233000,422606000,171856000,171856000,,-8110000,,,,17633000,721789000,549933000,299183000,-7902000,,146321000,146219000,53467000,1274069000,1606292000,440576000,114068000,82612000,2047407000,10628000,57524000,2000805000,155434000,238100000,-2844926000,254802000,175587000,526841000,8198000,49983000,-56514000,632359000,868679000,382005000,853316000,217597000,71933000,3503000.0,-19460000.0,-104184000.0,26039000.0,18617000.0,70294000.0,-361000.0,822000.0,193116000.0,24651000.0,4163000.0,-15132000.0,3673000.0,-19210000.0,-507000.0,-121933000.0,341838000,en-US,US,EQUITY,True,Delayed Quote,NMS,USD,676.9,1630526403,3.1400146,671.64,678.42,659.27,394867,673.76,0.0,0.0,8,8,finmb_29729,NasdaqGS,"IDEXX Laboratories, Inc.",USD,353360,400700,329.36002,0.9476895,347.54 - 706.95,-30.049988,-0.042506523,347.54,706.95,1620109808,1635337800,1635769800,87.10591,PRE,us_market,"IDEXX Laboratories, Inc.",0,False,False,2,0.0,0.0,1630570607,676.9,0.4660435,659.27 - 678.42,7.771,9.1,8.37,80.87217,8.232,679.24774,-2.3477173,-0.003456349,579.6309,97.269104,0.16781214,57726509056,74.38461,82.22789,15,America/New_York,EDT,-14400000,0.89,,,706.95,347.54,679.25,579.63,353.36k,400.7k,85.28M,,84.43M,0.95%,87.56%,852.23k,2.66,1.13%,1.00%,701.34k,,,,,,0.00%,,,2:1,"Jun 15, 2015","Dec 30, 2020","Mar 30, 2021",23.59%,27.92%,23.67%,166.25%,2.86B,33.48,24.20%,1.57B,895.67M,674.21M,7.77,82.70%,351.16M,4.12,999.84M,142.14,1.77,8.23,744.61M,557.21M,Value,04092,Healthcare,9300,5,4,"IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.",Westbrook,207 556 0300,ME,8,1609372800,1622505600,1,United States,http://www.idexx.com,86400,5,One IDEXX Drive,207 556 4346,Diagnostics & Research
t-3,IDXX,-18082000,85280704,31645000,,183822000,437000,148940000,154449000,379342000,193248000,193248000,,-9495000,,,,34826000,637592000,444344000,258250000,-9426000,,148996000,148940000,55619000,1247456000,1687313000,272963000,114815000,92007000,1960713000,10603000,58198000,1854586000,178505000,235426000,-2839682000,256754000,105293000,540584000,7575000,121596000,-51630000,633302000,779612000,354949000,899562000,229377000,73903000,-9259000.0,-24556000.0,-161531000.0,69421000.0,10403000.0,23898000.0,-64000.0,1843000.0,208142000.0,23582000.0,-14820000.0,-19215000.0,9493000.0,-24556000.0,-6068000.0,-165802000.0,239028000,en-US,US,EQUITY,True,Delayed Quote,NMS,USD,676.9,1630526403,3.1400146,671.64,678.42,659.27,394867,673.76,0.0,0.0,8,8,finmb_29729,NasdaqGS,"IDEXX Laboratories, Inc.",USD,353360,400700,329.36002,0.9476895,347.54 - 706.95,-30.049988,-0.042506523,347.54,706.95,1620109808,1635337800,1635769800,87.10591,PRE,us_market,"IDEXX Laboratories, Inc.",0,False,False,2,0.0,0.0,1630570607,676.9,0.4660435,659.27 - 678.42,7.771,9.1,8.37,80.87217,8.232,679.24774,-2.3477173,-0.003456349,579.6309,97.269104,0.16781214,57726509056,74.38461,82.22789,15,America/New_York,EDT,-14400000,0.89,,,706.95,347.54,679.25,579.63,353.36k,400.7k,85.28M,,84.43M,0.95%,87.56%,852.23k,2.66,1.13%,1.00%,701.34k,,,,,,0.00%,,,2:1,"Jun 15, 2015","Dec 30, 2020","Mar 30, 2021",23.59%,27.92%,23.67%,166.25%,2.86B,33.48,24.20%,1.57B,895.67M,674.21M,7.77,82.70%,351.16M,4.12,999.84M,142.14,1.77,8.23,744.61M,557.21M,Value,04092,Healthcare,9300,5,4,"IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.",Westbrook,207 556 0300,ME,8,1609372800,1622505600,1,United States,http://www.idexx.com,86400,5,One IDEXX Drive,207 556 4346,Diagnostics & Research
